- Home
- PSNL vs FORA Comparison
PSNL vs FORA Comparison
Compare PSNL & FORA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PSNL
- FORA
- Stock Information
- Founded
- PSNL 2011
- FORA 2014
- Country
- PSNL United States
- FORA United States
- Employees
- PSNL N/A
- FORA N/A
- Industry
- PSNL Medical Specialities
- FORA Computer Software: Prepackaged Software
- Sector
- PSNL Health Care
- FORA Technology
- Exchange
- PSNL Nasdaq
- FORA Nasdaq
- Market Cap
- PSNL 321.1M
- FORA 63.8M
- IPO Year
- PSNL 2019
- FORA N/A
- Fundamental
- Price
- PSNL $5.19
- FORA $2.10
- Analyst Decision
- PSNL Strong Buy
- FORA Strong Buy
- Analyst Count
- PSNL 4
- FORA 1
- Target Price
- PSNL $6.81
- FORA $5.00
- AVG Volume (30 Days)
- PSNL 439.4K
- FORA 14.2K
- Earning Date
- PSNL 11-06-2024
- FORA 11-07-2024
- Dividend Yield
- PSNL N/A
- FORA N/A
- EPS Growth
- PSNL N/A
- FORA N/A
- EPS
- PSNL N/A
- FORA 0.06
- Revenue
- PSNL $80,027,000.00
- FORA $20,371,880.00
- Revenue This Year
- PSNL $10.85
- FORA N/A
- Revenue Next Year
- PSNL $8.77
- FORA $10.64
- P/E Ratio
- PSNL N/A
- FORA $36.34
- Revenue Growth
- PSNL 19.20
- FORA 6.97
- 52 Week Low
- PSNL $0.89
- FORA $2.00
- 52 Week High
- PSNL $7.20
- FORA $4.15
- Technical
- Relative Strength Index (RSI)
- PSNL 56.29
- FORA 38.13
- Support Level
- PSNL $4.54
- FORA $2.05
- Resistance Level
- PSNL $5.35
- FORA $2.16
- Average True Range (ATR)
- PSNL 0.30
- FORA 0.05
- MACD
- PSNL 0.05
- FORA 0.00
- Stochastic Oscillator
- PSNL 84.71
- FORA 31.77
About PSNL Personalis Inc.
Personalis Inc is a provider of genomic sequencing and analytics solutions to support the development of personalized cancer vaccines and other next-generation cancer immunotherapies. It has one segment, the sale of sequencing and data analysis services. Its products include ImmunoID NeXT, NeXT Personal, NeXT Dx Test, and other pharma research solutions.
About FORA Forian Inc.
Forian Inc provides a suite of Software, data management capabilities, and proprietary data and analytics to optimize and measure operational, clinical, and financial performance for customers within the traditional and emerging life sciences, healthcare payer, and provider segments, as well as cannabis dispensaries, manufacturers, and cultivators.